March 11, 2020 – PRA Health Sciences, the owner and operator of Symphony Health, today announced a partnership between Symphony Health and Datavant that allows life sciences companies to build fit-for-purpose data assets and strategies to support the development and delivery of new drugs.
Datavant connects the country's largest ecosystem of linkable real-world data, while protecting patient privacy and maintaining each partner's control over their data.
Through this partnership, Symphony’s customers will be able to link de-identified Symphony data at the patient level to electronic health records, medical and pharmacy claims, diagnostic lab data sets, and demographic and behavioral data. The ability to link de-identified data across datasets offers Symphony's customers unprecedented flexibility to craft custom data strategies, tailored to relevant therapeutic areas and patient needs.
For more information, click here.
Datavant's mission is to connect the world's health data to improve patient outcomes. Datavant works with data owners and users to ensure that data can be connected to power next-generation analytics and applications while protecting patient privacy. Datavant is headquartered in San Francisco. Learn more about Datavant at www.datavant.com.
Bob Borek, Head of Marketing & Strategic Partnerships